Skip to content

Effectiveness of Fu's Subcutaneous Needling on mastalgia in patients with mammary gland hyperplasia.

Effectiveness of Fu's Subcutaneous Needling on mastalgia in patients with mammary gland hyperplasia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073253
Enrollment
Unknown
Registered
2023-07-05
Start date
2023-07-05
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperplasia of mammary glands

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1)Women aged 20-50 years . (2)Meet the diagnostic criteria of traditional Chinese and Western medicine for HGM. (3)VAS score of breast: 4 =VAS =10; (4)Have not taken Chinese and Western drugs to treat HMG in the past two weeks, such as hormones and so on. (5)First time receiving FSN,and willing to sign informed consent and cooperate with treatment.

Exclusion criteria

Exclusion criteria: (1) Having infection, benign or malignant breast tumors. (2) Having general contraindications, such as being pregnant,lactation and (or ) having functional uterine bleeding. (3) Having serious primary diseases of the heart, liver, kidney and (or ) hematopoietic system. (4) Having cognitive dysfunction and being unable to cooperate with the entire experiment. (5) Accepting other treatments for HGM.

Design outcomes

Primary

MeasureTime frame
Short-form of Mc Gill pain questionnaire;

Secondary

MeasureTime frame
shearwaveelasticityimagin;curative effect;Blind index; Breast pain VAS score;

Countries

China

Contacts

Public ContactXu Fei

Guangdong Provincial Hospital of Chinese Medicine

fifixu@163.com+86 137 6067 1966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026